Profund Advisors’s Rhythm Pharmaceuticals RYTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $711K | Sell |
11,254
-1,190
| -10% | -$75.2K | 0.03% | 379 |
|
|
2025
Q1 | $659K | Buy |
12,444
+1,963
| +19% | +$104K | 0.03% | 396 |
|
|
2024
Q4 | $587K | Sell |
10,481
-2,877
| -22% | -$161K | 0.02% | 433 |
|
|
2024
Q3 | $700K | Sell |
13,358
-617
| -4% | -$32.3K | 0.03% | 415 |
|
|
2024
Q2 | $574K | Sell |
13,975
-20,306
| -59% | -$834K | 0.02% | 458 |
|
|
2024
Q1 | $1.49M | Buy |
34,281
+13,790
| +67% | +$598K | 0.06% | 232 |
|
|
2023
Q4 | $942K | Sell |
20,491
-7,327
| -26% | -$337K | 0.04% | 339 |
|
|
2023
Q3 | $638K | Sell |
27,818
-19,262
| -41% | -$442K | 0.04% | 399 |
|
|
2023
Q2 | $776K | Buy |
47,080
+705
| +2% | +$11.6K | 0.04% | 388 |
|
|
2023
Q1 | $827K | Buy |
+46,375
| New | +$827K | 0.05% | 352 |
|